Literature DB >> 29921518

Interbreed variation in serum serotonin (5-hydroxytryptamine) concentration in healthy dogs.

K Höglund1, J Häggström2, S Hanås3, A-C Merveille4, V Gouni5, M Wiberg6, J Lundgren Willesen7, K Mc Entee8, L Mejer Sørensen7, L Tiret9, E H Seppälä10, H Lohi10, V Chetboul5, M Fredholm7, A-S Lequarré4, I Ljungvall2.   

Abstract

INTRODUCTION: Serotonin (5-hydroxytryptamine [5-HT]) has several biological functions. In different species, excessive 5-HT has been linked to valvular lesions, similar to those seen in dogs with myxomatous mitral valve disease. Previous studies suggest higher 5-HT in healthy Cavalier King Charles Spaniels (CKCSs), a breed highly affected by myxomatous mitral valve disease, compared to other breeds.
OBJECTIVE: To investigate potential interbreed variation in serum 5-HT in healthy dogs. ANIMALS: 483 healthy dogs of nine breeds aged 1-7 years.
METHODS: Dogs were examined at five European centers. Absence of cardiovascular, organ-related, or systemic diseases was ensured by thorough clinical investigations including echocardiography. Serum was frozen and later analyzed by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Median 5-HT concentration was 252.5 (interquartile range = 145.5-390.6) ng/mL. Overall breed difference was found (p<0.0001), and 42% of pairwise breed comparisons were significant. Univariate regression analysis showed association between serum 5-HT concentration and breed, center of examination, storage time, and sex, with higher 5-HT in females. In multiple regression analysis, the final model had an adjusted R2 of 0.27 with breed (p<0.0001), center (p<0.0001), and storage time (p=0.014) remaining significant. Within centers, overall breed differences were found at 3/5 centers (p≤0.028), and pairwise comparisons within those centers showed breed differences in 42% of comparisons. Among the included breeds, Newfoundlands, Belgian Shepherds and CKCSs had highest 5-HT concentrations.
CONCLUSIONS: Interbreed variation in serum 5-HT concentration was found in healthy dogs aged 1-7 years. These differences should be taken into account when designing clinical studies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-HT; Biomarker; Breed difference; Canine; Heart valve

Mesh:

Substances:

Year:  2018        PMID: 29921518     DOI: 10.1016/j.jvc.2018.05.002

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  6 in total

Review 1.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

2.  Serotonin and Tryptophan Serum Concentrations in Shelter Dogs Showing Different Behavioural Responses to a Potentially Stressful Procedure.

Authors:  Giacomo Riggio; Chiara Mariti; Valeria Sergi; Silvana Diverio; Angelo Gazzano
Journal:  Vet Sci       Date:  2020-12-24

3.  Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.

Authors:  Maria J Reimann; Merete Fredholm; Signe E Cremer; Liselotte B Christiansen; Kathryn M Meurs; Jacob E Møller; Jens Häggström; Jens Lykkesfeldt; Lisbeth H Olsen
Journal:  J Vet Intern Med       Date:  2021-10-02       Impact factor: 3.333

4.  Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers.

Authors:  Dmitrij Arkadievich Oleynikov; Ma Yi
Journal:  Open Vet J       Date:  2022-07-14

5.  Short-term effect of ovariohysterectomy on urine serotonin, cortisol, testosterone and progesterone in bitches.

Authors:  Eva Hydbring-Sandberg; Elin Larsson; Andrzej Madej; Odd Viking Höglund
Journal:  BMC Res Notes       Date:  2021-07-10

6.  Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.

Authors:  G R Markby; V E Macrae; B M Corcoran; K M Summers
Journal:  BMC Vet Res       Date:  2020-09-23       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.